
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Galactosemia natural history, complications and prognosis
Introduction
Overview
Overview
Galactosemia is an inherited metabolic disorder with a variable natural history. It can lead to severe systemic complications if neglected. The prognosis depends on various factors.
Natural History
Natural History
Acute neonatal illness is experienced by most patients. A reported lower enzyme activity leads to more severe presentation while newborn screening results in detection at more favorable stages of the disease. Clinical features include [1] having one or more of:
A younger age of diagnosis and early introduction of dietary changes exert a positive effect on the natural history of galactosemia [2] [3].
Complications
Complications
Despite dietary modifications, most of the galactosemic patients develop neurological and/or gonadal complications and are at risk of bone damage [1].
Neurological , cognitive and behavioral complications [4]:
- Tremor: Most often seen in the second decade of life [1]
- General motor abnormality ataxia
- Seizures
- Dystonia
- Anxiety disorder: It is the most frequently reported mental problem and common in all age categories, usually after the second decade.
- ADHD, ASD: More likely before the second decade
Gonadal complications
- Premature ovarian insufficiency and subfertility [5]
- Cryptorchidism [6]
- Delayed psychosexual development [7]
Bone complications
Prognosis
Prognosis
The prognostic outcome of galactosemia depends on a number of factors [1]:
- Newborn screening: Associated with lower rates of neurological symptoms
- Enzyme activity: Enzyme acitivity <1% correlates with more severe mental and behavioral symptoms.
- Diet: Onset of diet in the first week of life is associated with a more favorable prognosis. Moreover, a relaxed diet (lactose free without any further restrictions) has been proven to be more beneficial than a strict diet for long-term clinical outcomes [9].
References
References
- ↑ 1.0 1.1 1.2 1.3 Rubio-Gozalbo ME, Haskovic M, Bosch AM, Burnyte B, Coelho AI, Cassiman D; et al. (2019). “The natural history of classic galactosemia: lessons from the GalNet registry”. Orphanet J Rare Dis. 14 (1): 86. doi:10.1186/s13023-019-1047-z. PMC 6486996. PMID 31029175.
- ↑ Berry GT, Nissim I, Gibson JB, Mazur AT, Lin Z, Elsas LJ; et al. (1997). “Quantitative assessment of whole body galactose metabolism in galactosemic patients”. Eur J Pediatr. 156 Suppl 1: S43–9. doi:10.1007/pl00014271. PMID 9266215.
- ↑ Berry GT (2012). “Galactosemia: when is it a newborn screening emergency?”. Mol Genet Metab. 106 (1): 7–11. doi:10.1016/j.ymgme.2012.03.007. PMID 22483615.
- ↑ Rubio-Agusti I, Carecchio M, Bhatia KP, Kojovic M, Parees I, Chandrashekar HS; et al. (2013). “Movement disorders in adult patients with classical galactosemia”. Mov Disord. 28 (6): 804–10. doi:10.1002/mds.25348. PMID 23400815.
- ↑ Frederick AB, Zinsli AM, Carlock G, Conneely K, Fridovich-Keil JL (2018). “Presentation, progression, and predictors of ovarian insufficiency in classic galactosemia”. J Inherit Metab Dis. 41 (5): 785–790. doi:10.1007/s10545-018-0177-0. PMC 6128750. PMID 29721917.
- ↑ Gubbels CS, Welt CK, Dumoulin JC, Robben SG, Gordon CM, Dunselman GA; et al. (2013). “The male reproductive system in classic galactosemia: cryptorchidism and low semen volume”. J Inherit Metab Dis. 36 (5): 779–86. doi:10.1007/s10545-012-9539-1. PMID 23053469.
- ↑ Gubbels CS, Maurice-Stam H, Berry GT, Bosch AM, Waisbren S, Rubio-Gozalbo ME; et al. (2011). “Psychosocial developmental milestones in men with classic galactosemia”. J Inherit Metab Dis. 34 (2): 415–9. doi:10.1007/s10545-011-9290-z. PMC 3112026. PMID 21350966.
- ↑ van Erven B, Welling L, van Calcar SC, Doulgeraki A, Eyskens F, Gribben J; et al. (2017). “Bone Health in Classic Galactosemia: Systematic Review and Meta-Analysis”. JIMD Rep. 35: 87–96. doi:10.1007/8904_2016_28. PMC 5585100. PMID 27995581.
- ↑ Van Calcar SC, Bernstein LE, Rohr FJ, Scaman CH, Yannicelli S, Berry GT (2014). “A re-evaluation of life-long severe galactose restriction for the nutrition management of classic galactosemia”. Mol Genet Metab. 112 (3): 191–7. doi:10.1016/j.ymgme.2014.04.004. PMID 24857409.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dayana Davidis, M.D. [2]
